• A cohort of 17 patients with kyphoscoliotic Ehlers-Danlos syndrome caused by biallelic mutations in FKBP14: expansion of the clinical and mutational spectrum and description of the natural history
• A mother and three daughters with congenital dislocation of the hip and a characteristic facial appearance: a new syndrome?
• A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts
• Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
• Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
• Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic
• Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
• Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
• Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
• Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020
• Genomic reconstruction of the SARS-CoV-2 epidemic in England
• Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes
• Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
• Mortality and AIDS-defining events among young people following transition from paediatric to adult HIV care in the UK
• Phenotypic variability of distal 22q11.2 copy number abnormalities
• Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study
• Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
• The association of premorbid conditions with 6-month mortality in acutely admitted ICU patients over 80 years
• The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study
• Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme